SavedAdd your journal

Journals / Turkish Journal of Hematology / 2018 / Cilt: 35 - Sayı: 2

Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy

Kutanöz Anaplastik Büyük Hücreli Lenfomada Brentuksimab Vedotin Monoterapisi ile Düzelme

Takashi ONAKA
Tomoya KITAGAWA
Chika KAWAKAMI
Akihito YONEZAWA
Pages
135–136
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Abstract

-

🔖

Cite This Article

ONAKA, T., KITAGAWA, T., KAWAKAMI, C., YONEZAWA, A. (2022). Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy. Turkish Journal of Hematology, Cilt: 35 - Sayı: 2, 135–136. https://ajindex.com/articles/607057

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Katz J, Janik JE, Younes A. Brentuximab vedotin (SGN-35). Clin Cancer Res 2011;17:6428-6436
  2. Desai A, Telang GH, Olszewski AJ. Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin. Ann Hematol 2013;92:567-568
  3. Kaffenberger BH, Kartono Winardi F, Frederickson J, Porcu P, Wong HK. Periocular cutaneous anaplastic large cell lymphoma clearance with brentuximab vedotin. J Clin Aesthet Dermatol 2013;6:29-31.